Suppression of Cellular Apoptosis Susceptibility (CSE1L) Inhibits Proliferation and Induces Apoptosis in Colorectal Cancer Cells |
Zhu, Jin-Hui
(Department of General Surgery and Laparoscopic Center, Second Affiliated Hospital, Zhejiang University School of Medicine)
Hong, De-Fei (Department of Hepatobiliarypancreatic Surgery, Zhejiang Province People's Hospital) Song, Yong-Mao (Department of Surgical Oncology, Second Affiliated Hospital, Zhejiang University School of Medicine) Sun, Li-Feng (Department of Surgical Oncology, Second Affiliated Hospital, Zhejiang University School of Medicine) Wang, Zhi-Fei (Department of Hepatobiliarypancreatic Surgery, Zhejiang Province People's Hospital) Wang, Jian-Wei (Department of Surgical Oncology, Second Affiliated Hospital, Zhejiang University School of Medicine) |
1 | Akiyama Y, Watkins N, Suzuki H, et al (2003). GATA-4 and GATA-5 transcription factor genes and potential downstream antitumor target genes are epigenetically silenced in colorectal and gastric cancer. Mol Cell Biol, 23, 8429. DOI |
2 | Behrens P, Brinkmann U, Fogt F, Wernert N, Wellmann A (2001). Implication of the proliferation and apoptosis associated CSE1L/CAS gene for breast cancer development. Anticancer Res, 21, 2413-7. |
3 | Behrens P, Brinkmann U, Wellmann A (2003). CSE1L/CAS: its role in proliferation and apoptosis. Apoptosis, 8, 39-44. DOI ScienceOn |
4 | Bera TK, Bera J, Brinkmann U, Tessarollo L, Pastan I (2001). Cse1l is essential for early embryonic growth and development. Mol Cell Biol, 21, 7020-4. DOI ScienceOn |
5 | Brinkmann U, Brinkmann E, Bera TK, Wellmann A, Pastan I (1999). Tissue-Specific Alternative Splicing of the CSE1L/CAS (Cellular Apoptosis Susceptibility) Gene* 1. Genomics, 58, 41-9. DOI ScienceOn |
6 | Castanotto D, Rossi JJ (2009). The promises and pitfalls of RNA-interference-based therapeutics. Nature, 457, 426-33. DOI ScienceOn |
7 | Chintharlapalli S, Papineni S, Lei P, Pathi S, Safe S (2011). Betulinic acid inhibits colon cancer cell and tumor growth and induces proteasome-dependent and -independent downregulation of specificity proteins (Sp) transcription factors. BMC Cancer, 11, 371. DOI |
8 | Eberhart CE, Coffey R, Radhika A, et al (1994). Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology, 107, 1183. |
9 | Kim JG, Chae YS, Sohn SK, et al (2008). Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with colorectal cancer. Clin Cancer Res, 14, 62. DOI ScienceOn |
10 | Liao CF, Luo SF, Shen TY, et al (2008). CSE1L/CAS, a microtubule-associated protein, inhibits taxol (paclitaxel)-induced apoptosis but enhances cancer cell apoptosis induced by various chemotherapeutic drugs. BMB Rep, 41, 210-6. DOI ScienceOn |
11 | Liao CF, Luo SF, Li LT, et al (2008). CSE1L/CAS, the cellular apoptosis susceptibility protein, enhances invasion and metastasis but not proliferation of cancer cells. J Exp Clin Canc Res, 27, 15. DOI ScienceOn |
12 | Mulkeen AL, Silva T, Yoo PS, et al (2006). Short Interfering RNA-Mediated Gene Silencing of Vascular Endothelial Growth Factor: Effects on Cellular Proliferation in Colon Cancer Cells. Arch Surg, 141, 367-74. DOI ScienceOn |
13 | Tai CJ, Shen SC, Lee WR, et al (2010). Increased cellular apoptosis susceptibility (CSE1L/CAS) protein expression promotes protrusion extension and enhances migration of MCF-7 breast cancer cells. Exp Cell Res, 316, 2969-81. DOI ScienceOn |
14 | O'Brien CA, Pollett A, Gallinger S, Dick JE (2007). A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature, 445, 106-10. DOI ScienceOn |
15 | Pai SI, Lin YY, Macaes B, et al (2005). Prospects of RNA interference therapy for cancer. Gene Ther, 13, 464-77. |
16 | Suzuki H, Watkins DN, Jair KW, et al (2004). Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet, 36, 417-22. DOI ScienceOn |
17 | Tsao TY, Tsai CS, Tung JN, et al (2009a). Function of CSE1L/CAS in the secretion of HT-29 human colorectal cells and its expression in human colon. Mol Cell Biocheml, 327, 163-70. DOI |
18 | Tsao TY, Tsai CSS, Tung JN, et al (2009b). Function of CSE1L/CAS in the secretion of HT-29 human colorectal cells and its expression in human colon. Mol Cell Biocheml, 327, 163-70. DOI |
19 | Tung MC, Tsai CSS, Tung JN, et al (2009). Higher prevalence of secretory CSE1L/CAS in sera of patients with metastatic cancer. Cancer Epidem Biomar, 18, 1570. DOI ScienceOn |
20 | Wellmann A, Flemming P, Behrens P, et al (2001). High expression of the proliferation and apoptosis associated CSE1L/CAS gene in hepatitis and liver neoplasms: correlation with tumor progression. Int J Mol Med, 7, 489. |
21 | Zhang S, Yang JH, Guo CK, Cai P (2007). Gene silencing of TKTL1 by RNAi inhibits cell proliferation in human hepatoma cells. Cancer Lett, 253, 108-14. DOI ScienceOn |